Skip to content

Charles River Laboratories CRL Less: Net income from noncontrolling interests

Less: Net income from noncontrolling interests at other companies

Hyatt Hotels logo
Hyatt HotelsH
-$0.06
The Kraft Heinz Company logo
The Kraft Heinz CompanyKHC
$0
RenaissanceRe Holdings logo
RenaissanceRe HoldingsRNR
$54.48M+44.9%
The Kraft Heinz Company logo
The Kraft Heinz CompanyKHC
$0
Equitable Holdings logo
Equitable HoldingsEQH
Corebridge Financial logo
Corebridge FinancialCRBG

Other financials

Income statement

See full
Revenue$995.8M+1.2%
Gross profit$349.0M-3.5%
Operating income$119.9M+60.6%
Net income-$14.8M-158%
EPS (diluted)-$0.30-160%

Balance sheet

See full
Cash & equivalents$198.2M-14.5%
Total debt$3.1B+1.9%
Total equity$2.9B-7.9%
Total assets$7.7B+2.0%

Cash flow

See full
Operating cash flow$41.1M-76.1%
CapEx$55.9M-5.8%
Free cash flow-$14.8M-113%

Valuation

See full
Market cap$8.91B+10.3%
Enterprise value$11.79B+8.5%
P/S2.2×+0.2×

Profitability

See full
Gross margin84.7%
Operating margin13%-2.4pp
Net margin-4.6%
FCF margin9.7%-4.3pp

Returns & leverage

See full
Return on equity-6%
Debt / equity+0.1×
Current ratio1.4×-0.1×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:NetIncomeLossAttributableToNoncontrollingInterest.

The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Charles River Laboratories's less: net income from noncontrolling interests.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Charles River Laboratories's less: net income from noncontrolling interests?
Charles River Laboratories (CRL) reported less: net income from noncontrolling interests of $41K in Q1 2026.
How has Charles River Laboratories's less: net income from noncontrolling interests changed year-over-year?
Charles River Laboratories's less: net income from noncontrolling interests decreased by 90.0% year-over-year, from $409K to $41K.
What is the long-term trend for Charles River Laboratories's less: net income from noncontrolling interests?
Over 2 years (2023 to 2025), Charles River Laboratories's less: net income from noncontrolling interests has grown at a -38.5% compound annual growth rate (CAGR), from $5.75M to $2.18M.